U.S. Banks Stock News

NasdaqGS:UNIT
NasdaqGS:UNITTelecom

The Bull Case For Uniti Group (UNIT) Could Change Following Elevation To Cato Advanced Partner Tier

Uniti Solutions previously announced that it renewed its multi‑year partnership with Cato Networks Ltd. and was elevated to an ‘Advanced Partner’ status, a designation held by less than 2% of Cato’s global partners, reinforcing its managed SASE offering underpinned by Uniti’s fiber connectivity and Cato’s cloud‑native SASE platform. This recognition, alongside consecutive ‘Service Provider of the Year’ awards from Cato, underscores Uniti’s depth of SASE implementation expertise and its...
NYSE:MANU
NYSE:MANUEntertainment

Manchester United (MANU) Could Be 40% Below Fair Value Following Midfield Signings

Transfer activity links on-pitch plans with Manchester United stock Manchester United (MANU) has moved to strengthen its midfield with the arrival of Carlos Baleba, alongside Youri Tielemans and Andrey Santos, as the club prepares for Champions League participation under Michael Carrick. Manchester United’s share price has eased in the last week but remains on a strong upswing this year, with a year to date share price return of 48.92% and a 1 year total shareholder return of 37.51%. These...
NYSE:VLO
NYSE:VLOOil and Gas

Is Analyst Upgrades and Earnings Optimism Altering The Investment Case For Valero Energy (VLO)?

In recent months, analysts have grown more optimistic on Valero Energy, with multiple brokerage upgrades, higher earnings estimates, and a Zacks Rank #1 (Strong Buy) reflecting greater confidence in its near-term outlook. At the same time, commentators highlight that this analyst enthusiasm sits alongside concerns that the stock may be trading above fair value estimates, with regulatory and asset-impairment risks still in focus. Next, we'll examine how this wave of positive earnings...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Gibraltar Industries (ROCK) Conference Appearance Keeps Fair Value Debate In Focus

Conference spotlight and why Gibraltar Industries stock is on watch Gibraltar Industries (ROCK) is set to present at the Seaport 15th Annual Summer Investor Conference on August 18, 2026. CFO Joseph Allen Lovechio and CEO William T. Bosway will address investors. This appearance gives investors a closer look at how management views the Residential, Agtech, and Infrastructure segments, and how current performance metrics align with Gibraltar Industries’ longer term capital allocation and...
NYSE:DXC
NYSE:DXCIT

Does DXC’s New AI-Native Workplace Platform Subtly Reframe Its Turnaround Story for Investors (DXC)?

Earlier this year, DXC Technology launched DXC Workplace Services, an AI-native workplace offering designed to boost employee productivity, IT efficiency, and user experience. The move underscores DXC’s push to turn its AI capabilities into concrete workplace solutions, at a time when its longer-term performance has been mixed. Next, we’ll examine how launching an AI-native workplace platform may reshape DXC’s turnaround-focused investment narrative built around digital...
NYSE:BMNR
NYSE:BMNRSoftware

Bitmine Immersion Technologies (BMNR) Could Be A Bargain On Fresh Ethereum Buying

Bitmine Immersion Technologies (BMNR) is back on investors radar after new Ethereum purchases pushed its holdings close to 5% of total ETH supply, alongside a disclosed US$14.9b crypto and moonshot portfolio. The latest Ethereum buying and the disclosed US$14.9b crypto and moonshot portfolio have gone hand in hand with a sharp rebound in Bitmine Immersion Technologies. The 30-day share price return is 39.01% and the 90-day share price return is 29.40%. However, the share price return year to...
NYSE:PRIM
NYSE:PRIMConstruction

Primoris Services (PRIM) Could Be 35% Undervalued After Shareholder Lawsuit Scrutiny

A new shareholder class action lawsuit targeting Primoris Services (PRIM) has put the company’s fixed price renewable energy projects and project oversight processes under scrutiny, raising fresh questions for investors about cost estimation and risk management. The lawsuit comes after a difficult stretch for Primoris Services shareholders, with the 90 day share price return down 38.25% and the year to date share price return down 40.14%, even though the 5 year total shareholder return is...
NYSE:PRI
NYSE:PRIInsurance

Higher Treasury Yields Could Lift Primerica Stock And Other Life Insurers

Long term US Treasury yields have pushed above 5.3% on the 30 year, and that ripple is reaching far beyond the bond market. Higher discount rates are reshaping how investors think about future cash flows, while concerns over US deficits and inflation keep talk of higher for longer alive. This article walks through three US life insurers and annuity providers that are directly exposed to these moves and explains what that could mean for their stocks. The three stocks covered next are only a...
NasdaqGS:AXTI
NasdaqGS:AXTISemiconductor

Does AXT (AXTI) Pair Buybacks and Bullish Signals to Redefine Its Semiconductor Narrative?

AXT, Inc. recently completed a long-running share repurchase program totaling 907,530 shares for US$2.28 million and earlier this month presented at the 7th Annual Needham Virtual Semiconductor & SemiCap 1×1 Conference, highlighting its compound semiconductor substrate business to investors. Technical traders are watching a hammer chart pattern in AXT’s stock alongside increasingly positive earnings estimate revisions and a top Zacks Rank, together pointing to strengthening confidence in the...
NYSE:AVTR
NYSE:AVTRLife Sciences

Can Avantor (AVTR) Justify Its Valuation After Raising Its 2026 Outlook?

Avantor (AVTR) raised its 2026 outlook after second quarter results tied to its Revival program, which has supported earlier growth in VWR and stronger Bioscience & Medtech Products orders despite ongoing margin pressure. Avantor's recent Revival update has landed against a sharp swing in sentiment, with a 90 day share price return of 58.47% and a 30 day share price return of 23.30%, even though the 3 year total shareholder return declined 34.36% and the 5 year total shareholder return...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Expedia Group (EXPE) Insider Sale Draws Focus, Is The Stock Already Fully Valued?

Recent insider activity at Expedia Group (EXPE) is drawing attention after Chief Legal Officer and Secretary Robert J. Dzielak sold 4,334 shares in mid August while retaining a substantial stake in the company. Expedia Group's share price has climbed strongly in recent months, with a 30 day share price return of 19.78% and a 90 day share price return of 46.53% leading into a current level of $333.44. At the same time, the 1 year total shareholder return of 58.59% and 3 year total shareholder...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

Regulatory Momentum Around Oncolytic Virus Therapy Could Be A Game Changer For CG Oncology (CGON)

Recent developments around CG Oncology’s investigational oncolytic immunotherapy cretostimogene grenadenorepvec, now in Phase III bladder cancer trials with prior US FDA Fast Track and Breakthrough Therapy Designations, have drawn fresh attention to the company’s role in the emerging oncolytic virus cancer therapy field. This momentum underscores how regulatory support and clinical progress in engineered virus-based treatments are increasingly shaping interest in CG Oncology and its...
NYSE:ONTO
NYSE:ONTOSemiconductor

Is Onto Innovation (ONTO) A Bargain As Earnings Estimates Rise And A Hammer Pattern Forms?

Onto Innovation (ONTO) has drawn fresh attention after reports of a hammer chart pattern on its stock, alongside higher earnings estimates from Wall Street analysts and a favorable Zacks Rank #2 rating. At a latest share price of $291.88, Onto Innovation has shown strong momentum over the year, with a year to date share price return of 75.97% and a 1 year total shareholder return of 170.28%, even though the 7 day share price return declined 2.54% after a 12.78% 90 day share price...
NYSE:BXP
NYSE:BXPOffice REITs

BXP (BXP) Q2 Outlook Puts Its Valuation Back In Focus

Q2 earnings update and immediate market reaction BXP (BXP) moved after its Q2 financial report, which pointed to expectations for faster earnings this year. For investors, this kind of outlook often becomes a key reference point for reassessing the stock. Over the past year, BXP has seen mixed momentum, with the 1 day share price return down 2.54% after the Q2 release, while the 90 day share price return of 15.95% and the 3 year total shareholder return of 22.70% point to gains that investors...
NYSE:WAT
NYSE:WATLife Sciences

Does Tina Wu’s New Role Reframe Waters’ (WAT) Management Bench Strength And Strategic Focus?

Waters Corporation recently disclosed that Senior Vice President of the Waters Analytical Sciences Division, Robert L. Carpio III, resigned in August 2026, with Tina Wu, currently Senior Vice President of the Waters Materials Sciences Division and President, China, and a former DuPont executive, stepping into the role. Wu’s appointment brings more than two decades of large-scale, business-to-business leadership experience, potentially reshaping how Waters aligns its analytical sciences...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

Is Willis Towers Watson (WTW) Undervalued After Its Analyst Upgrade Raised Earnings Estimates?

Willis Towers Watson (WTW) drew fresh attention after a recent analyst upgrade, which cited higher earnings estimates as a key factor. That shift in expectations is now central to how many investors view the stock. The recent analyst upgrade comes after a strong run in Willis Towers Watson’s share price, with a 30 day share price return of 13.38% and a 90 day share price return of 36.15%. The 3 year total shareholder return of 70.90% points to momentum that has built over time rather than...
NYSE:BROS
NYSE:BROSHospitality

Dutch Bros (BROS) Could Be 34% Undervalued After Seasonal Drink Launches

Seasonal Drinks Return As Dutch Bros Stock Pullback Draws Attention Dutch Bros (BROS) has brought back its Caramel Pumpkin Brûlée and Cookie Butter drinks and launched the new Autumn Berry offering, just as the stock has fallen sharply over the past month. For Dutch Bros, the seasonal menu arrives after a sharp reset in sentiment, with the share price down about 22% over the past month and the 1-year total shareholder return declining roughly 30%, although the 3-year total shareholder return...
NYSE:TDY
NYSE:TDYElectronic

Teledyne’s New Army Thermal-Sensing Role Could Be A Game Changer For Teledyne Technologies (TDY)

Teledyne FLIR OEM recently announced it was selected to support the U.S. Army’s DUTCH initiative, advancing next-generation uncooled thermal infrared sensing to improve performance while cutting size, weight, power, and cost for high-volume defense applications. This award strengthens Teledyne’s role in secure, U.S.-based thermal sensor supply chains and underscores its system-integration capabilities for future uncrewed and imaging systems. We’ll now examine how Teledyne’s expanded role in...
NYSE:ECG
NYSE:ECGConstruction

Everus Construction Group (ECG) Could Be 32% Below Fair Value Following Analyst Upgrades

Everus Construction Group (ECG) moved into focus after analysts collectively raised their earnings estimates, and the stock was identified as a top pick in recent research screens. At a recent share price of $121.18, Everus Construction Group has seen mixed momentum, with the share price return down 6.47% over the past week and 20.02% over the past 90 days, yet still up 35.88% year to date and supported by a 56.71% total shareholder return over the past year. This suggests that recent...
NYSE:HTB
NYSE:HTBBanks

Higher For Longer Rates Are Putting These U.S. Bank Stocks Back In Focus

Sticky inflation, a more hawkish sounding Federal Reserve, and higher market yields are pushing investors to rethink how they are positioned for a longer stretch of elevated rates. That mix can hurt some corners of the market, yet it can also create interesting openings where stronger balance sheets and solid profitability meet more generous interest income. This article explores three U.S. financial stocks exposed to that story and how the latest data could matter for each one. These three...
NYSE:ENVA
NYSE:ENVAConsumer Finance

Can Enova International's (ENVA) Non-Prime Push Redefine Its Digital Lending Moat?

Enova International recently reported a strong second quarter, with revenue, EBITDA and EPS all exceeding analyst expectations as it expanded its online lending operations to non-prime consumers and small businesses in the US and Brazil. The results highlight how Enova’s focused digital model in under-served credit segments can translate into operational momentum across multiple geographic markets. Next, we’ll explore how this earnings outperformance and expanding online lending footprint...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Did Corebridge’s 2036 Debt Raise Just Shift Corebridge Financial's (CRBG) Investment Narrative?

In August 2026, Corebridge Financial, Inc. completed a fixed-income offering of callable, senior unsecured fixed-rate notes, including 5.900% notes due August 20, 2036, raising about US$748.55 million at a slight discount to face value. This sizeable bond issuance highlights how Corebridge is tapping debt markets to support its funding mix, capital structure flexibility, and future corporate priorities. We’ll now explore how this sizable 2036 fixed-rate notes issuance could influence...
NasdaqGS:STEP
NasdaqGS:STEPCapital Markets

Is STEP’s Fully Raised Infrastructure Secondaries Fund Quietly Redefining StepStone Group’s (STEP) Core Strategy?

StepStone Group has already completed fundraising for its StepStone Secondaries Infrastructure Fund and related separate accounts, securing US$1.70 billion in capital commitments focused on acquiring limited partner stakes and GP‑led infrastructure secondary deals, with around half of this capital reportedly deployed across 26 transactions, many in the middle market. This marks StepStone’s first closed‑ended commingled fund dedicated solely to infrastructure secondaries, underscoring the...
NasdaqGM:ANIP
NasdaqGM:ANIPPharmaceuticals

How Investors Are Reacting To ANI Pharmaceuticals (ANIP) Board Shake-Up And Strategic Expertise Addition

ANI Pharmaceuticals, Inc. has added Henry Gosebruch, a former AbbVie Executive Vice President and current biotechnology CEO, to its Board of Directors effective August 19, 2026, while Muthusamy (Samy) Shanmugam resigned from the Board but remains Head of Research and Development and Chief Operating Officer of New Jersey Operations. This change brings in a director with deep experience in corporate strategy, business development, and M&A, while preserving operational continuity through...